Jennifer B Hillman1, Rachel J Miller, Thomas H Inge. 1. Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA. jennifer.hillman@cchmc.org
Abstract
OBJECTIVE: Adolescent obesity has dramatically increased in recent decades, and along with that so have other medical comorbidities, such as hypertension, diabetes, hyperlipidemia, nonalcoholic steatohepatitis, polycystic ovary syndrome (PCOS), and pseudotumor cerebri. Obesity and related comorbidites may be contraindications to hormonal contraception, making contraception counseling of morbidly obese adolescents more challenging. Obese adolescent females seeking bariatric surgery need effective contraception in the postoperative period. This study is designed to determine the acceptance rate of the levonorgestrel-releasing intrauterine device (IUD) and describe common menstrual problems in obese adolescent bariatric surgery patients. METHODS: This is a historic cohort study of adolescent females who underwent bariatric surgery over a 2-year period at a tertiary referral center for pediatric obesity. Data were systematically abstracted. The percent of patients with menstrual problems and the acceptance rate for the levonorgestrel-releasing IUD were determined. RESULTS: Twenty-five adolescents met inclusion criteria. The mean age was 17.4 years (standard deviation [SD] 2.6), and the mean body mass index (BMI) was 51.4 (SD 6.3) kg/m(2). Eighty-four percent were white. Twenty-eight percent had menorrhagia, 32% had oligomenorrhea, 40% had dysmenorrhea, and 36% had PCOS. Ninety-two percent (23 of 25) underwent IUD placement. CONCLUSIONS: There was a high prevalence of menstrual problems among this sample of severely obese adolescent females. The majority accepted the IUD, indicating it is a viable option among this population.
OBJECTIVE:Adolescent obesity has dramatically increased in recent decades, and along with that so have other medical comorbidities, such as hypertension, diabetes, hyperlipidemia, nonalcoholic steatohepatitis, polycystic ovary syndrome (PCOS), and pseudotumor cerebri. Obesity and related comorbidites may be contraindications to hormonal contraception, making contraception counseling of morbidly obese adolescents more challenging. Obese adolescent females seeking bariatric surgery need effective contraception in the postoperative period. This study is designed to determine the acceptance rate of the levonorgestrel-releasing intrauterine device (IUD) and describe common menstrual problems in obese adolescent bariatric surgery patients. METHODS: This is a historic cohort study of adolescent females who underwent bariatric surgery over a 2-year period at a tertiary referral center for pediatric obesity. Data were systematically abstracted. The percent of patients with menstrual problems and the acceptance rate for the levonorgestrel-releasing IUD were determined. RESULTS: Twenty-five adolescents met inclusion criteria. The mean age was 17.4 years (standard deviation [SD] 2.6), and the mean body mass index (BMI) was 51.4 (SD 6.3) kg/m(2). Eighty-four percent were white. Twenty-eight percent had menorrhagia, 32% had oligomenorrhea, 40% had dysmenorrhea, and 36% had PCOS. Ninety-two percent (23 of 25) underwent IUD placement. CONCLUSIONS: There was a high prevalence of menstrual problems among this sample of severely obese adolescent females. The majority accepted the IUD, indicating it is a viable option among this population.
Authors: Peter L Schilling; Matthew M Davis; Craig T Albanese; Sanjeev Dutta; John Morton Journal: J Am Coll Surg Date: 2007-10-18 Impact factor: 6.113
Authors: Amy K Whitaker; Lisa M Johnson; Bryna Harwood; Laurel Chiappetta; Mitchell D Creinin; Melanie A Gold Journal: Contraception Date: 2008-07-03 Impact factor: 3.375
Authors: Gabriella G Gosman; Wendy C King; Beth Schrope; Kristine J Steffen; Gladys W Strain; Anita P Courcoulas; David R Flum; John R Pender; Hyagriv N Simhan Journal: Fertil Steril Date: 2009-10-07 Impact factor: 7.329
Authors: Thomas H Inge; Anita P Courcoulas; Todd M Jenkins; Marc P Michalsky; Mary L Brandt; Stavra A Xanthakos; John B Dixon; Carroll M Harmon; Mike K Chen; Changchun Xie; Mary E Evans; Michael A Helmrath Journal: N Engl J Med Date: 2019-05-16 Impact factor: 91.245
Authors: J N Becnel; M H Zeller; J G Noll; D B Sarwer; J Reiter-Purtill; M Michalsky; J Peugh; F M Biro Journal: Pediatr Obes Date: 2016-05-30 Impact factor: 4.000
Authors: Megan M Kelsey; Barbara H Braffett; Mitchell E Geffner; Lynne L Levitsky; Sonia Caprio; Siripoom V McKay; Rachana Shah; Jennifer E Sprague; Silva A Arslanian Journal: J Clin Endocrinol Metab Date: 2018-06-01 Impact factor: 5.958
Authors: Marco Milone; Giuseppe De Placido; Mario Musella; Loredana Maria Sosa Fernandez; Laura Virginia Sosa Fernandez; Gabriele Campana; Matteo Nicola Dario Di Minno; Francesco Milone Journal: Obes Surg Date: 2016-02 Impact factor: 4.129